125516 -

It is specifically indicated for the treatment of pediatric patients with high-risk neuroblastoma .

It is a chimeric GD2-binding monoclonal antibody that helps the immune system identify and destroy neuroblastoma cells. 125516

It connects to a DC718B USB High Speed Data Collection Board via a J2 connector. It is specifically indicated for the treatment of

The decision focused on the configuration of a basic matrix storage module used for storing information and check bits, ensuring specific mathematical inequalities were met to optimize error correction in data transmission. 4. Miscellaneous References The decision focused on the configuration of a

In European legal contexts, refers to a specific decision by the European Patent Office (EPO) Boards of Appeal regarding ZTE Corporation.

, with the Biologics License Application (BLA) number 125516 , is an orphan drug developed by United Therapeutics .